A Joint Model for the Kinetics of CTC Count and PSA Concentration During Treatment in Metastatic Castration‐Resistant Prostate Cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 2163-8306|4|5|277-285

ISSN： 2163-8306

Source： Cpt: Pharmacometrics & Systems Pharmacology, Vol.4, Iss.5, 2015-05, pp. : 277-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sipuleucel-T: In Metastatic Castration-Resistant Prostate Cancer

By Plosker Greg L.  

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 101-108

Adis International

Access to resources Recommend Favorite

Abiraterone Acetate: In Metastatic Castration-Resistant Prostate Cancer

By Yang Lily P.H.  

Drugs, Vol. 71, Iss. 15, 2011-10 ,pp. : 2067-2077

Adis International

Access to resources Recommend Favorite

Abiraterone Acetate: A Guide to Its Use in Metastatic Castration-Resistant Prostate Cancer

By Scott Lesley J.   Yang Lily P.H.   Lyseng-Williamson Katherine A.  

Drugs & Aging, Vol. 29, Iss. 3, 2012-03 ,pp. : 243-248

Adis International

Access to resources Recommend Favorite

Management of Metastatic Castration-Resistant Prostate Cancer: Recent Advances

By Mukherji Deborah   Eichholz Andrew   De Bono Johann S.  

Drugs, Vol. 72, Iss. 8, 2012-05 ,pp. : 1011-1028

Adis International

Access to resources Recommend Favorite

Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer

By  

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 1-13

Bentham Science Publishers

Access to resources Recommend Favorite